Key result
rs450819 polymorphism shows no link to metabolic syndrome risk in DYRK1B mutation carriers.
Why the study?
Does the rs450819 polymorphism increase the risk of metabolic syndrome in individuals with DYRK1B gene mutations?
Observational (n=121)
Does the rs450819 polymorphism increase the risk of metabolic syndrome in individuals with DYRK1B gene mutations?
Answers are grounded in this paper and cite their sources.
The rs450819 polymorphism is not associated with an increased risk of metabolic syndrome in patients with DYRK1B gene mutations.
Background: Metabolic syndrome is the clustering of multiple factors that directly increase the risk of cardiovascular disease and type 2 diabetes. Two missense mutations of the DYRK1B gene, including H90P and R102C, were recently found to co-segregate with a rare autosomal-dominant form of metabolic syndrome, called abdominal obesity-metabolic syndrome (AOMS3). Affected individuals developed early-onset cardiovascular disease, hypertension, central obesity, and diabetes. Conclusions: Objectives: The DYRK1B R102C mutation significantly increases the key gluconeogenic enzyme and glucose-6-phosphatase. Methods: In this research, we evaluated the association between single nucleotide polymorphism (SNP) rs4508194 and metabolic syndrome in individuals with DYRK1B gene mutations. The rs450819 genotypes are determined by polymerase chain reaction in 121 heterozygote and homozygote subjects in the DYRK1B gene. PCR products were sequenced, and then a survey was conducted on the sequences. Data were analyzed with chi-square statistical testing and Prism6 and SPSS software. Results: The results do not show a correlation between these SNP alleles and increased metabolic syndrome risk in individuals suffering from metabolic syndrome and its risk factors. Conclusions: The rs450819 SNP genotypes do not play a role in the development of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Dezh et al. (2025) conducted an observational in Metabolic syndrome (n=121). rs450819 polymorphism was evaluated on Metabolic syndrome. The rs450819 polymorphism showed no correlation with increased metabolic syndrome risk in individuals with DYRK1B gene mutations.
Synapse has enriched 10 related papers. Consider them for comparative context: